Patents by Inventor Brendan P. Keegan

Brendan P. Keegan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
    Patent number: 7790162
    Abstract: The present invention discloses antibodies, antigen binding fragments, peptides and peptidomimetics immunoreactive with provasopressin and compositions thereof, methods of phenotyping tissue samples, methods of treating cancer, and kits for phenotyping test biopsy samples and bodily fluids for breast cancer, small cell lung cancer, ductal carcinoma in situ, and atypical ductal hyperplasia.
    Type: Grant
    Filed: July 16, 2003
    Date of Patent: September 7, 2010
    Assignee: Woomera Therapeutics, Inc.
    Inventors: William G. North, Brendan P. Keegan, Lyn Oligino
  • Compositions And Uses Thereof For Identifying And Targeting Provasopressin-Expressing Cancer Cells
    Publication number: 20080050376
    Abstract: The present invention discloses antibodies, antigen binding fragments, peptides and peptidomimetics immunoreactive with provasopressin and compositions thereof, methods of phenotyping tissue samples, methods of treating cancer, and kits for phenotyping test biopsy samples and bodily fluids for breast cancer, small cell lung cancer, ductal carcinoma in situ, and atypical ductal hyperplasia.
    Type: Application
    Filed: July 16, 2003
    Publication date: February 28, 2008
    Inventors: William G. North, Brendan P. Keegan, Lyn Oligino